Circulation

MAY 20, 2024

Obesity is a recognized public health epidemic with a prevalence that continues to increase dramatically in nearly all populations, impeding progress in reducing incidence rates of cardiovascular disease. Circulation, Ahead of Print.

Obesity 78

Obesity Public Health Research Cardiovascular Disease 78

Frontiers in Cardiovascular Medicine

APRIL 23, 2024

Cardiovascular disease (CVD) is the leading cause of death worldwide, accounting for over one-third of all deaths in Singapore. Furthermore, other major risk factors, such as diabetes mellitus, hypertension, elevated low-density lipoprotein levels, and obesity, are steadily rising. billion USD (11.5 billion SGD).

Cardiovascular Disease 52

Cardiovascular Disease Risk Factors Obesity Article 52

Medical Xpress - Cardiology

JULY 9, 2024

Semaglutide reduces cardiovascular events, regardless of baseline glycated hemoglobin (HbA1c), among people with overweight or obesity and established atherosclerotic cardiovascular disease, according to a study published online June 22 in Diabetes Care.

Obesity 52

Obesity Cardiovascular Disease Diabetes 52

Cardiology Update

JANUARY 24, 2024

The 2023 Almanac results derived from the Global Burden of Disease (GBD) and spanning 1990 to 2022, were recently published in the Journal of American College of Cardiology. The post Global Trends in Cardiovascular Diseases: Insights from the 2023 Almanac appeared first on Cardiology Update. Original article: Mensah GA et al.

Cardiovascular Disease 119

Cardiovascular Disease Research Blood Pressure Public Health 119

Journal of the American Heart Association

FEBRUARY 14, 2024

Driven by common pathophysiologic underpinnings (eg, inflammation and neurohormonal dysregulation), cardiovascular disease, cognitive impairment, and frailty also share the following risk factors: hypertension, diabetes, obesity, sedentary behavior, and tobacco use.

Cardiovascular Disease 73

Cardiovascular Disease Dementia Obesity Risk Factors 73

Cardiovascular Diabetology

JULY 10, 2024

The triglyceride-glucose (TyG) index and its combination with obesity indicators can predict cardiovascular diseases (CVD). However, there is limited research on the relationship between changes in the triglyc.

Cardiovascular Disease 52

Cardiovascular Disease Obesity Research 52

Cardiometabolic Health Congress

FEBRUARY 1, 2024

Other studies have also unearthed more intricate connections which suggests that physiological conditions, underpinned by biological and chemical factors, may also play a pivotal role in influencing cardiovascular disease (CVD). In 2021 alone, CVD accounted for over 900,000 deaths in the U.S. and approximately 19.91 million globally.

Cardiovascular Disease 105

Cardiovascular Disease Coronary Artery Bypass Graft Heart Disease Risk Factors 105

Cardiometabolic Health Congress

JANUARY 3, 2024

In today’s society, the prevalence of obesity has become a significant concern. have obesity, and this rate has increased by more than 10 percentage points in the past two decades. Understanding the prevalence of obesity is crucial in comprehending why events like Healthy Weight Week are essential. of adults in the U.S.

Obesity 97

Obesity Diabetes Blood Pressure BMI 97

The British Journal of Cardiology

AUGUST 6, 2024

Obesity is a global pandemic and is a recognised risk factor for cardiovascular diseases. Therefore, we conducted an observational study with a cohort of 196 participants, comparing various echocardiographic parameters in normal weight individuals and those who were overweight or obese but had no other risk factors.

Obesity 52

Obesity Risk Factors Cardiovascular Disease Cardiac Function 52

American College of Cardiology

JANUARY 8, 2024

Obesity is a multifaceted disease that is directly and indirectly implicated in atherosclerotic cardiovascular disease (CVD), heart failure (HF), atrial fibrillation (AF), and multiple CVD risk factors, including dyslipidemia, hypertension, type 2 diabetes mellitus (DM), and sleep disorders.

Obesity 71

Obesity Atrial Fibrillation Heart Failure Risk Factors 71

Cardiovascular Diabetology

MAY 28, 2024

Triglyceride and glucose (TyG) index, a surrogate marker of insulin resistance, has been validated as a predictor of cardiovascular disease. However, effects of TyG-related indices combined with obesity marker.

Cardiovascular Disease 52

Cardiovascular Disease Obesity Research 52

Journal of the American Heart Association

DECEMBER 29, 2023

Multivariable logistic models evaluated associations of RARs with prevalent CVD, hypertension, obesity, and central adiposity. Participants (mean age, 49 years) in the highest versus lowest tertile of relative amplitude (greater circadian rhythmicity) had 39% to 62% lower odds of prevalent CVD, hypertension, obesity, and central adiposity.

Obesity 40

Obesity Cardiovascular Disease Hypertension 40

Frontiers in Cardiovascular Medicine

JANUARY 22, 2024

Introduction Cardiovascular diseases (CVDs) are the most important cause of premature death and disability worldwide. The etiological risk factors of CVDs are widely known and include dyslipidemia, obesity, diabetes, and chronic cigarette consumption.

Cardiovascular Disease 64

Cardiovascular Disease Risk Factors Obesity Physiology 64

DAIC

JANUARY 23, 2024

Atherosclerotic cardiovascular disease (ASCVD), caused by plaque buildup in arterial walls, is one of the leading causes of disability and death worldwide.1,2 1,2 ASCVD causes or contributes to conditions that include coronary artery disease (CAD), cerebrovascular disease, and peripheral vascular disease (inclusive of aortic aneurysm).3

Cardiovascular Disease 111

Cardiovascular Disease Heart Attack Heart attacks Coronary Artery Disease 111

Circulation

JUNE 4, 2024

We projected through 2050, overall and by age and race and ethnicity, accounting for changes in disease prevalence and demographics.RESULTS:We estimate that among adults, prevalence of hypertension will increase from 51.2% to 26.8%) and obesity (43.1% Prevalences of coronary disease (7.8% in 2020 to 61.0% Diabetes (16.3%

Risk Factors 81

Risk Factors Cardiovascular Disease Stroke Strokes 81

Cardiometabolic Health Congress

JULY 25, 2023

Can you please explain the concept of an obesity paradox? Salvatore Carbone, PhD: First, I’d like to point out that obesity is a major risk factor for cardiometabolic disease. 2, 3] This association is more pronounced for those with class I obesity, which is a body mass index (BMI) between 30-35 kg/m2.

Obesity 52

Obesity BMI Heart Failure Cardiovascular Disease 52

American Heart News - Heart News

NOVEMBER 11, 2023

Research Highlights: In a large, international clinical trial, people with obesity or overweight but not diabetes taking semaglutide for more than 3 years had a 20% lower risk of heart attack, stroke or death due to cardiovascular disease and lost an.

Obesity 52

Obesity Diabetes Heart Attack Heart attacks 52

The New England Journal of Medicine

NOVEMBER 10, 2023

In a trial in patients with cardiovascular disease and overweight or obesity but no diabetes, semaglutide was superior to placebo in lowering the risk of major adverse cardiovascular events at a mean follow-up of 39.8

Obesity 40

Obesity Diabetes Cardiovascular Disease Outcomes 40

Med Page Today

MARCH 8, 2024

(MedPage Today) -- The FDA approved semaglutide (Wegovy) to reduce the risk of cardiovascular death, heart attack, and stroke in adults with cardiovascular disease and either obesity or overweight, the agency announced on Friday. A GLP-1 receptor.

Heart Disease 141

Heart Disease Heart Attack Heart attacks Obesity 141

Science Daily - Heart Disease

AUGUST 26, 2024

The study also estimates eligibility and associated maximum costs if different definitions of cardiovascular risk were to be considered. If Medicare Part D narrowly defines cardiovascular disease, majority of patients would remain ineligible while new federal spending could still exceed $10 billion.

Medicare 54

Medicare Obesity Cardiovascular Disease 54

Science Daily - Heart Disease

OCTOBER 10, 2023

Pregnancy complications such as preeclampsia and gestational diabetes have recently been associated with a higher risk of developing heart disease later in life. But a new study has found obesity before or during pregnancy is the actual root cause of future cardiovascular disease. “We

Obesity 40

Obesity Heart Disease Cardiovascular Disease Diabetes 40

Circulation: Genomic and Precision Medicine

NOVEMBER 28, 2023

Background:Proteomic profiling could potentially disclose new pathophysiological pathways for cardiovascular diseases (CVD) and improve prediction at the individual level. Circulation: Genomic and Precision Medicine, Ahead of Print.

Cardiovascular Disease 40

Cardiovascular Disease Myocardial Infarction Obesity Heart Failure 40

Circulation: Heart Failure

OCTOBER 27, 2023

BACKGROUND:Right ventricular (RV) dysfunction is associated with increased mortality across a spectrum of cardiovascular diseases. The role of obesity in RV dysfunction and adverse outcomes is unclear.METHODS:We examined patients undergoing right heart catheterization between 2005 and 2016 in a hospital-based cohort.

Obesity 40

Obesity Outcomes Heart Failure Pulmonary 40

European Journal of Heart Failure

DECEMBER 13, 2023

Association between epicardial adipose tissue (EAT) and cardiac dysfunction in severe obesity. Abstract Aim Epicardial adipose tissue (EAT) plays a role in obesity-related heart failure with preserved ejection fraction. BMI, body mass index; GLS, global longitudinal strain; LASct, left atrial contractile strain. p  = 0.045).

Obesity 40

Obesity Preserved Ejection Fraction BMI Heart Failure 40

Frontiers in Cardiovascular Medicine

JANUARY 4, 2024

Cardiovascular diseases (CVD) are the leading cause of mortality and morbidity worldwide. The study reveals a link between Zn, Cu, and the Zn/Cu ratio and cardiovascular disease risk. A higher Zn/Cu ratio may protect against CVD, while elevated Cu levels are linked to obesity, fibrinogen levels, and HbA1C.

Cardiovascular Disease 59

Cardiovascular Disease Blood Pressure Diet Obesity 59

Medical Xpress - Cardiology

APRIL 2, 2024

Changes in the gut microbiome have been implicated in a range of diseases including type 2 diabetes, obesity, and inflammatory bowel disease.

Heart Disease 104

Heart Disease Obesity Cardiovascular Disease Diabetes 104

Open Heart

JUNE 9, 2023

Body mass index (BMI) ‘(weight (kg)/height (m) 2 ) was calculated and patients with BMI ≥30 kg/m 2 were categorised as obese. kg/m 2 and 23.2% (255) were categorised as obese. On multivariable analysis, obesity showed paradoxical protective effect with adjusted OR of 0.59 (95% CI 0.36 to 7.15, p=0.007).

Obesity 52

Obesity BMI Thrombosis Hospital 52

Cardiometabolic Health Congress

JUNE 7, 2024

Ballantyne, MD , emphasized that while fellows may consider prevention “boring,” it is crucial for avoiding resource-intensive late-stage cardiovascular disease (CVD). He highlighted that cardiovascular health is essential for cognitive health, noting the common occurrence of vascular dementia.

Cardiovascular Disease 59

Cardiovascular Disease Obesity Heart Disease Risk Factors 59

CardiacWire

MARCH 24, 2024

Less than two weeks after Novo Nordisk’s weight-loss drug Wegovy gained expanded FDA approval for cardiovascular event risk reduction, CMS issued a new Medicare Part D guidance that allows coverage of obesity drugs for senior patients with “an additional medically accepted indication”… like cardiovascular disease.

Medicare 59

Medicare Obesity CMS Medicaid 59

Journal of Clinical Investigation - Cardiology

JULY 15, 2024

These circadian mechanisms represent potential pathophysiological pathways linking circadian disruption to adverse metabolic health outcomes, including obesity, metabolic syndrome, and type 2 diabetes.

Diabetes 145

Diabetes Obesity Cancer Risk Factors 145

Journal of Clinical Investigation - Cardiology

DECEMBER 15, 2023

Metabolic syndrome, today affecting more than 20% of the US population, is a group of 5 conditions that often coexist and that strongly predispose to cardiovascular disease. How these conditions are linked mechanistically remains unclear, especially two of these: obesity and elevated blood pressure.

Blood Pressure 103

Blood Pressure Obesity Pharmacology Diet 103

Cardiovascular Diabetology

JANUARY 2, 2024

Obesity has increased in recent years with consequences on diabetes and other comorbidities. Thus, 1 out of 3 diabetic patients suffers cardiovascular disease (CVD). The network among glucose, immune system, e.

Obesity 66

Obesity Diabetes Cardiovascular Disease Research 66

Stroke Journal

FEBRUARY 1, 2024

Meanwhile, Metabolically healthy obesity (MHO) trends are understudied in association with stroke. Patients were categorized into a metabolically healthy obese MHO+ve cohort, BMI> 30, and MHO-ve cohort, BMI<30. Stroke, Volume 55, Issue Suppl_1 , Page ATP262-ATP262, February 1, 2024.

Obesity 40

Obesity Hospital Stroke Strokes 40

CardiacWire

MAY 8, 2024

A new JAMA study revealed that a shocking 90% of US adults are at risk of developing cardiovascular-kidney-metabolic (CKM) syndrome, underscoring the need for preventative action before we face a wave of CKM-related heart disease. Stage 4 (heart disease, with or without kidney disease) – 9.2% in Whites).

Kidney Disease 116

Kidney Disease Obesity Risk Factors Diabetes 116

Open Heart

MAY 23, 2024

Pre-eclampsia and heart failure have common risk factors, including hypertension, obesity and diabetes. Multiple logistic regression analysis was used to evaluate the impact of heart failure on the risk of pre-eclampsia, with adjustment for established risk factors and other cardiovascular diseases.

Heart Disease 98

Heart Disease Heart Failure Risk Factors Obesity 98

Frontiers in Cardiovascular Medicine

JULY 17, 2024

Recently, indisputable evidence has shown that the TyG index is strongly associated with cardiovascular disease [CVD, including atherosclerosis, heart failure (HF), and hypertension] prognosis and mortality. Finally, we summarized the mechanism of the “obesity paradox.”

Heart Failure 64

Heart Failure Atherosclerosis Biomarkers Obesity 64

Frontiers in Cardiovascular Medicine

DECEMBER 20, 2023

years; p  < 0.001), had more cardiovascular risk factors, target organ damage and cardiovascular disease (CVD) in comparison with those without hypertension. These patients were older (65.8 ± 10.9 vs. 51.6 ± 14.7 Conclusions About half of patients attended in primary care settings have hypertension in Spain.

Blood Pressure 134

Blood Pressure Hypertension Obesity Risk Factors 134